Hepatitis A Virus Transmission by Blood Products in the United States
- 1 June 1994
- journal article
- Published by Wiley in Vox Sanguinis
- Vol. 67 (s1), 24-28
- https://doi.org/10.1111/j.1423-0410.1994.tb00970.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Solvent/detergent-treated clotting factors and hepatitis A virus seroconversionThe Lancet, 1993
- Passive antibody to hepatitis A virus in US haemophiliacsThe Lancet, 1993
- Absence of hepatitis A after treatment with pasteurised factor VIII concentrates in children with haemophilia A and von Willebrand diseaseThe Lancet, 1993
- Prevalence of serum IgG antibodies to hepatitis A virus in Italian haemophiliacsThe Lancet, 1992
- Outbreak of hepatitis A among Italian patients with haemophiliaThe Lancet, 1992
- Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group.BMJ, 1992
- Removal of parvovirus B19 from contaminated factor VIII during fractionationJournal of Medical Virology, 1991
- Transmission of Human Immunodeficiency Virus Type 1 by Dry‐Heated Clotting Factor Concentrates1Vox Sanguinis, 1990
- Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening, The Transfusion Safety Study/NHLBI Donor RepositoryTransfusion, 1989
- Appearance of immune complexes during experimental hepatitis A infection in chimpanzeesJournal of Medical Virology, 1988